The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

F.J. Schmitz

Institute for Medical Microbiology and Virology

Heinrich-Heine-Universität Düsseldorf

Germany

[email]@uni-duesseldorf.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Institute for Medical Microbiology and Virology, Heinrich-Heine-Universität Düsseldorf, Germany. 1999 - 2002
  • Eijkman-Winkler Institute for Clinical Microbiology, Utrecht University, Netherlands. 1999 - 2001
  • Institute for Medical Microbiology and Virology, Germany. 2000

References

  1. Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureus. Schmitz, F.J., Boos, M., Mayer, S., Jagusch, H., Fluit, A.C. J. Antimicrob. Chemother. (2002) [Pubmed]
  2. Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates. Schmitz, F.J., Beeck, A., Perdikouli, M., Boos, M., Mayer, S., Scheuring, S., Köhrer, K., Verhoef, J., Fluit, A.C. J. Clin. Microbiol. (2002) [Pubmed]
  3. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. Schmitz, F.J., Higgins, P.G., Mayer, S., Fluit, A.C., Dalhoff, A. Eur. J. Clin. Microbiol. Infect. Dis. (2002) [Pubmed]
  4. Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae. Schmitz, F.J., Fisher, A., Boos, M., Mayer, S., Milatovic, D., Fluit, A.C. Eur. J. Clin. Microbiol. Infect. Dis. (2001) [Pubmed]
  5. Increased prevalence of class I integrons in Escherichia coli, Klebsiella species, and Enterobacter species isolates over a 7-year period in a German university hospital. Schmitz, F.J., Hafner, D., Geisel, R., Follmann, P., Kirschke, C., Verhoef, J., Köhrer, K., Fluit, A.C. J. Clin. Microbiol. (2001) [Pubmed]
  6. Treatment options for Streptococcus pneumoniae strains resistant to macrolides, tetracycline, quinolones, or trimethoprim/sulfamethoxazole. Schmitz, F.J., Verhoef, J., Milatovic, D., Fluit, A.C. Eur. J. Clin. Microbiol. Infect. Dis. (2001) [Pubmed]
  7. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. Schmitz, F.J., Sadurski, R., Kray, A., Boos, M., Geisel, R., Köhrer, K., Verhoef, J., Fluit, A.C. J. Antimicrob. Chemother. (2000) [Pubmed]
  8. In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus. Schmitz, F.J., Fluit, A.C., Milatovic, D., Verhoef, J., Heinz, H.P., Brisse, S. J. Antimicrob. Chemother. (2000) [Pubmed]
  9. Distribution of macrolide-resistance genes in Staphylococcus aureus blood-culture isolates from fifteen German university hospitals. M.A.R.S. Study Group. Multicentre Study on Antibiotic Resistance in Staphylococci. Schmitz, F.J., Petridou, J., Fluit, A.C., Hadding, U., Peters, G., von Eiff, C. Eur. J. Clin. Microbiol. Infect. Dis. (2000) [Pubmed]
  10. Molecular analyses of possible mechanisms coding for low-level mupirocin resistance in clinical Staphylococcus aureus isolates. Schmitz, F.J., Fluit, A.C., Lindenlauf, E., Scheuring, S., Köhrer, K. Eur. J. Clin. Microbiol. Infect. Dis. (2000) [Pubmed]
  11. Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates. Schmitz, F.J., Fluit, A.C., Hafner, D., Beeck, A., Perdikouli, M., Boos, M., Scheuring, S., Verhoef, J., Köhrer, K., Von Eiff, C. Antimicrob. Agents Chemother. (2000) [Pubmed]
  12. Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme. Schmitz, F.J., Verhoef, J., Fluit, A.C. Eur. J. Clin. Microbiol. Infect. Dis. (1999) [Pubmed]
  13. Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals. SENTRY Participants Group. Schmitz, F.J., Verhoef, J., Fluit, A.C. Eur. J. Clin. Microbiol. Infect. Dis. (1999) [Pubmed]
  14. Susceptibility of 302 methicillin-resistant Staphylococcus aureus isolates from 20 European university hospitals to vancomycin and alternative antistaphylococcal compounds. SENTRY Participants Group. Schmitz, F.J., Krey, A., Geisel, R., Verhoef, J., Heinz, H.P., Fluit, A.C. Eur. J. Clin. Microbiol. Infect. Dis. (1999) [Pubmed]
  15. Comparative activities of six different fluoroquinolones against 9,682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme. The SENTRY participants group. Schmitz, F.J., Verhoef, J., Fluit, A.C. Int. J. Antimicrob. Agents (1999) [Pubmed]
 
WikiGenes - Universities